Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
search results for:
dealforma
Search
With a new $255M megaround in hand, Alex Zhavoronkov has big plans for Insilico. Are they feasible?
5 years ago
Financing
AI
Q1: A flood of investor cash drove biotech's numbers to new record highs, and the torrent of cash is moving upstream ...
5 years ago
Deals
The top 100 biopharma VCs, Bob Bradway places $2B bet in cancer, gene editing pioneer's new big idea, and more
5 years ago
Weekly
The 2021 top 100 biopharma investors: As the pandemic hit and IPOs boomed, VCs swung into action like never before
5 years ago
Financing
Special
The SPAC attack has just begun. And the Richard Branson deal is just the tip of the biotech iceberg
5 years ago
Financing
Top gene therapy deals, M&A pacts in 2020 highlight another big year in one of the hottest fields in biopharma
5 years ago
Deals
R&D
What do the top 10 biotech M&A deals of 2020 tell us? Premiums are in, bolt-ons rule and the ADC comeback is on
5 years ago
Startups
Deals
Here's a look at everything Merck's BD group has done in the past 12 years, illustrating why the Seattle Genetics ...
5 years ago
Deals
R&D
Which big biopharma player should gamble $34B on a ripe rare-disease M&A target? An action-hungry top analyst fills ...
5 years ago
Deals
The outlier: 2020 may go down as one of the biggest economic meltdowns in US history — but biopharma is booming
5 years ago
Financing
The home run count: The $100M+ mega-round boom in biotech inspired a $7.3B feeding frenzy — so far this year
6 years ago
Bioregnum
R&D
When times got tough, the biopharma industry hit the Zoom button and kept things moving at a multibillion-dollar clip
6 years ago
Deals
Dealmaking spiked to record levels in April as Covid-19 triggered a fever of partnering. But what happens to ...
6 years ago
Deals
Who's doing deals in the midst of a crippling pandemic? Here are the top 10 players for March
6 years ago
Deals
The big C: The dealmakers, dollars and diseases that have transformed the Chinese biopharma market
6 years ago
Financing
Deals
The top 100 biopharma venture investors at the megabillions deal table
6 years ago
Financing
Biotech was big in 2019, but here's one record no one wanted to see broken: Most bankruptcies
6 years ago
Pharma
Just how big is the biopharma dealmaking world? In 2019 we saw megabillions in cash change hands, and that's just the ...
6 years ago
Deals
First page
Previous page
2
3
4
5
6
7
Next page
Last page
latest
Most read
FDA's Makary calls for tying fast-review vouchers to lower US prices, without specifics
14 hours ago
Pharma
FDA+
Karyopharm cuts 20% of staff as it looks at 'strategic alternatives' or raising cash
12 hours ago
Financing
European regulators lift restriction on Valneva’s chikungunya vaccine
13 hours ago
Pharma
FDA+
Novartis dealt a blow in patent fight to block Entresto generics
13 hours ago
Pharma
Law
FDA kicks off latest reauthorization of generic drug user fee legislation
13 hours ago
FDA+
see latest stream
